Captrust Financial Advisors Takeda Pharmaceutical CO LTD Transaction History

Captrust Financial Advisors

$43.1 Billion
Q2 2025

A detailed history of Captrust Financial Advisors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Captrust Financial Advisors holds 38,440 shares of TAK stock, worth $533,547. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,440

Previous 36,251 6.04%

Holding current value

$533,547

Previous $539,000 10.2%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$13.71 - $15.46 $30,011 - $33,841	2,189 Added 6.04%	38,440 $594,000
Q1 2025 May 14, 2025	BUY	$12.89 - $15.19 $242,551 - $285,830	18,817 Added 107.93%	36,251 $539,000
Q4 2024 Feb 14, 2025	SELL	$13.01 - $14.43 $87,193 - $96,709	-6,702 Reduced 27.77%	17,434 $230,000
Q3 2024 Nov 14, 2024	SELL	$13.0 - $15.08 $25,558 - $29,647	-1,966 Reduced 7.53%	24,136 $342,000
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $151,200 - $164,040	-12,000 Reduced 31.49%	26,102 $337,000
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $253,145 - $274,104	-18,225 Reduced 32.36%	38,102 $529,000
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $41,228 - $47,616	-3,086 Reduced 5.19%	56,327 $803,000
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $403,540 - $438,175	26,849 Added 82.45%	59,413 $919,000
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $17,734 - $19,488	1,139 Added 3.62%	32,564 $511,000
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $78,019 - $84,146	-5,106 Reduced 13.98%	31,425 $517,000
Q4 2022 Feb 15, 2023	BUY	$12.42 - $15.62 $255,516 - $321,350	20,573 Added 128.92%	36,531 $570,000
Q3 2022 Nov 16, 2022	BUY	$12.8 - $28.65 $45,478 - $101,793	3,553 Added 28.64%	15,958 $207,000
Q2 2022 Aug 23, 2022	SELL	$13.12 - $15.03 $23,222 - $26,603	-1,770 Reduced 12.49%	12,405 $174,000
Q2 2022 Aug 16, 2022	BUY	$13.12 - $15.03 $75,321 - $86,287	5,741 Added 68.07%	14,175 $199,000
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $97,041 - $110,013	-7,167 Reduced 45.94%	8,434 $121,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $103,792 - $129,248	7,881 Added 102.09%	15,601 $213,000
Q3 2021 Nov 16, 2021	SELL	$16.3 - $17.26 $17,669 - $18,709	-1,084 Reduced 12.31%	7,720 $126,000
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $11,535 - $12,992	697 Added 8.6%	8,804 $148,000
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $33,169 - $39,501	1,985 Added 32.42%	8,107 $148,000
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $29,518 - $36,384	1,918 Added 45.62%	6,122 $111,000
Q3 2020 Nov 17, 2020	BUY	$17.1 - $19.19 $19,699 - $22,106	1,152 Added 37.75%	4,204 $74,000
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $44,528 - $59,514	3,052 New	3,052 $54,000

Others Institutions Holding TAK

# of Institutions

368

Shares Held

73.1M

Call Options Held

1.68M

Put Options Held

157K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Takeda Pharmaceutical CO LTD Transaction History